Daewon Pharmaceutical Co., Ltd. (KRX:003220)

Daewon Pharmaceutical Revenue

Daewon Pharmaceutical had revenue of 143.94B KRW in the quarter ending September 30, 2025, a decrease of -8.22%. This brings the company's revenue in the last twelve months to 590.70B, down -0.55% year-over-year. In the year 2024, Daewon Pharmaceutical had annual revenue of 598.16B with 13.51% growth.

• Revenue (ttm): 590.70B
• Revenue Growth: -0.55%
• P/S Ratio: 0.46
• Revenue / Employee: 460.40M
• Employees: 1,283
• Market Cap: 268.78B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	598.16B	71.21B	13.51%
Dec 31, 2023	526.95B	48.07B	10.04%
Dec 31, 2022	478.88B	124.71B	35.21%
Dec 31, 2021	354.18B	45.68B	14.81%
Dec 31, 2020	308.50B	-9.33B	-2.93%